Cargando…

Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies

Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Khayat, Maan T., Mohammad, Khadijah A., Mohamed, Gamal A., Safo, Martin K., Ibrahim, Sabrin R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782297/
https://www.ncbi.nlm.nih.gov/pubmed/36556460
http://dx.doi.org/10.3390/life12122095
_version_ 1784857308692480000
author Khayat, Maan T.
Mohammad, Khadijah A.
Mohamed, Gamal A.
Safo, Martin K.
Ibrahim, Sabrin R. M.
author_facet Khayat, Maan T.
Mohammad, Khadijah A.
Mohamed, Gamal A.
Safo, Martin K.
Ibrahim, Sabrin R. M.
author_sort Khayat, Maan T.
collection PubMed
description Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiveness because of their capability to biosynthesize novel bio-metabolites that reveal diversified bio-activities. A new tetracyclic triterpenoid, integracide L (1), along with integracides B (2) and F (3), were separated from Mentha longifolia-associated Fusarium sp. (FS No. MAR2014). Their structures were verified utilizing varied spectral analyses. The isolated metabolites (1–3), alongside the earlier reported integracides G (4), H (5), and J (6), were inspected for 5-LOX inhibition capacity. Interestingly, 1–6 possessed marked 5-LOX inhibition potentials with IC(50)s ranging from 1.18 to 3.97 μM compared to zileuton (IC(50) 1.17 µM). Additionally, molecular docking was executed to examine the interaction among these metabolites and 5-LOX, as well as to validate the in vitro findings. The docking study revealed their inhibitory activity interactions in the binding pocket. These findings highlighted the potential of integracides as lead metabolites for anti-inflammation drug discovery.
format Online
Article
Text
id pubmed-9782297
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97822972022-12-24 Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies Khayat, Maan T. Mohammad, Khadijah A. Mohamed, Gamal A. Safo, Martin K. Ibrahim, Sabrin R. M. Life (Basel) Article Inflammation is a complicated disorder that is produced as a result of consecutive processes. 5-LOX (5-lipoxygenase) is accountable for various inflammation mediators and leukotrienes synthesis, and its inhibition is the target of anti-inflammation therapeutics. Fungi have acquired enormous attentiveness because of their capability to biosynthesize novel bio-metabolites that reveal diversified bio-activities. A new tetracyclic triterpenoid, integracide L (1), along with integracides B (2) and F (3), were separated from Mentha longifolia-associated Fusarium sp. (FS No. MAR2014). Their structures were verified utilizing varied spectral analyses. The isolated metabolites (1–3), alongside the earlier reported integracides G (4), H (5), and J (6), were inspected for 5-LOX inhibition capacity. Interestingly, 1–6 possessed marked 5-LOX inhibition potentials with IC(50)s ranging from 1.18 to 3.97 μM compared to zileuton (IC(50) 1.17 µM). Additionally, molecular docking was executed to examine the interaction among these metabolites and 5-LOX, as well as to validate the in vitro findings. The docking study revealed their inhibitory activity interactions in the binding pocket. These findings highlighted the potential of integracides as lead metabolites for anti-inflammation drug discovery. MDPI 2022-12-13 /pmc/articles/PMC9782297/ /pubmed/36556460 http://dx.doi.org/10.3390/life12122095 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khayat, Maan T.
Mohammad, Khadijah A.
Mohamed, Gamal A.
Safo, Martin K.
Ibrahim, Sabrin R. M.
Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title_full Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title_fullStr Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title_full_unstemmed Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title_short Integracides: Tetracyclic Triterpenoids from Fusarium sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
title_sort integracides: tetracyclic triterpenoids from fusarium sp.—their 5-lipoxygenase inhibitory potential and structure–activity relation using in vitro and molecular docking studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782297/
https://www.ncbi.nlm.nih.gov/pubmed/36556460
http://dx.doi.org/10.3390/life12122095
work_keys_str_mv AT khayatmaant integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies
AT mohammadkhadijaha integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies
AT mohamedgamala integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies
AT safomartink integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies
AT ibrahimsabrinrm integracidestetracyclictriterpenoidsfromfusariumsptheir5lipoxygenaseinhibitorypotentialandstructureactivityrelationusinginvitroandmoleculardockingstudies